Q3 2024 Nephros Inc Earnings Call Transcript
Key Points
- Nephros Inc (NEPH) achieved its first profitable quarter since inception, reporting a net income of $0.2 million compared to a net loss of $0.2 million in Q3 of last year.
- Gross margin improved to 61% from 59% in Q3 2023, reflecting better terms with the largest supplier.
- SG&A expenses were reduced by 19% to $1.7 million from $2.1 million in Q3 2023, due to lower stock compensation and bonus accruals.
- Nephros Inc (NEPH) is expanding into new markets such as scale processing laboratories and dental practices, and exploring partnerships for solutions to emerging issues like nano and microplastic contaminations.
- The company is ramping up digital support tools for filter installation, which is expected to improve customer compliance and drive recurring revenues.
- Net revenue for Q3 2024 was $3.5 million, a 6% decline compared to Q3 2023, primarily due to a decline in programmatic revenue.
- Cash and cash equivalents decreased to $2.5 million as of September 30, 2024, from $4.3 million at the end of 2023, due to operating losses and inventory investments.
- The company faced challenges in specific regions, with some larger accounts showing slower order patterns.
- Emergency response revenue, which is not within the company's control, has disappointed, impacting overall revenue expectations.
- The commercial beverage business did not meet expectations, and growth in this area has been slower than anticipated.
Good day and welcome to the Nephros Inc third quarter, 2024 financial results conference call. All participants will be in listen-only mode. Should you need assistance? Please signal a conference specialist by pressing the star key followed by zero.
After today's presentation, there will be an opportunity to ask questions to ask a question. You may press star then one on your telephone keypad to withdraw your question. Please press star. Then two. Please note this event is being recorded.
I would now like to turn the conference over to Karen Smith with PC G advisory. Please go ahead.
Thank you, Debbie. Good afternoon, everyone and welcome to nephros' Q3 2024 earnings conference call.
Thank you all for participating in nephros' third quarter, 2024 conference call. Before we begin, I would like to remind you that this call will include forward-looking statements regarding the operations and future results of Nephros. For a discussion of these forward-looking statements. Please review
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
